iShares Neuroscience and Healthcare ETF (IBRN)
NYSEARCA: IBRN · Real-Time Price · USD
34.33
-0.14 (-0.42%)
Apr 28, 2026, 4:00 PM EDT - Market closed
IBRN Holdings Information
IBRN is an equity ETF with a total of 84 individual holdings. The top holdings are Xenon Pharmaceuticals stock at 4.71%, Arrowhead Pharmaceuticals at 4.43%, Alkermes at 4.15%, Axsome Therapeutics at 4.11%, and Praxis Precision Medicines at 3.96%.
Total Holdings
84
Top 10 Percentage
40.29%
Asset Class
Equity
ETF Category
Health
Assets
5.18M
PE Ratio
16.48
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | XENE | Xenon Pharmaceuticals Inc. | 4.71% |
| 2 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.43% |
| 3 | ALKS | Alkermes plc | 4.15% |
| 4 | AXSM | Axsome Therapeutics, Inc. | 4.11% |
| 5 | PRAX | Praxis Precision Medicines, Inc. | 3.96% |
| 6 | CNTA | Centessa Pharmaceuticals plc | 3.95% |
| 7 | ARGX | argenx SE | 3.87% |
| 8 | PTCT | PTC Therapeutics, Inc. | 3.87% |
| 9 | SRRK | Scholar Rock Holding Corporation | 3.66% |
| 10 | BIIB | Biogen Inc. | 3.58% |
| 11 | NBIX | Neurocrine Biosciences, Inc. | 3.57% |
| 12 | ACAD | ACADIA Pharmaceuticals Inc. | 3.53% |
| 13 | DNTH | Dianthus Therapeutics, Inc. | 3.37% |
| 14 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.20% |
| 15 | DNLI | Denali Therapeutics Inc. | 2.99% |
| 16 | SUPN | Supernus Pharmaceuticals, Inc. | 2.88% |
| 17 | EWTX | Edgewise Therapeutics, Inc. | 2.58% |
| 18 | DYN | Dyne Therapeutics, Inc. | 2.46% |
| 19 | SRPT | Sarepta Therapeutics, Inc. | 2.15% |
| 20 | AXGN | Axogen, Inc. | 2.12% |
| 21 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 2.06% |
| 22 | HLBBF | H. Lundbeck A/S | 1.98% |
| 23 | CAPR | Capricor Therapeutics, Inc. | 1.83% |
| 24 | TSHA | Taysha Gene Therapies, Inc. | 1.53% |
| 25 | STO: BIOA.B | BioArctic AB (publ) | 1.35% |
As of Apr 24, 2026